Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Interim Management Statement

15 Apr 2014 10:09

RNS Number : 8579E
Maven Income and Growth VCT 3 PLC
15 April 2014
 

 

Maven Income and Growth VCT 3 PLC (the Company)

 

Interim Management Statement - quarter ended 28 February 2014

 

This Interim Management Statement, for the quarter ended 28 February 2014, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 March 2014 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 83.42p per share at 28 February 2014, compared to 83.00p per share at 30 November 2013;

· NAV total return2 of 119.87p at 28 February 2014, compared to 119.45p at 30 November 2013; and

· Proposed final dividend of 3.25p per share in respect of the year ending 30 November 2013, to be paid on 30 May 2014.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 28 February 2014. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 November 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 28 February 2014, four new investments and one follow-on investment totalling a net amount of £1,772,110 were made in unlisted companies and a total of £1,998,349 was invested in UK Government Securities. In the same period, disposals from three AIM quoted investments generated aggregate proceeds of £223,327 against a cost of £164,236; a total of £953,005 of capital was returned from four unlisted companies and there was a deferred consideration from one unlisted company amounting to £26,860.

 

3.

Recent developments

 

Between 1 March 2014 and the date of this Statement, two new investments and three follow-on investments totalling £1,118,142 were made in unlisted companies and a disposal of an unlisted investment generated proceeds of £90,644 against a cost of £171,786. There was also a sale of UK Government Securities realising £999,126 against a cost of £999,174.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 December 2013 to 28 February 2014, or in the period from 1 March 2014 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

15 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMGMDLKNGDZG
Date   Source Headline
27th Mar 20185:44 pmRNSPublication of Suppl.Prospcts
9th Mar 20184:16 pmRNSAnnual Financial Report
8th Mar 20183:30 pmRNSDividend Declaration
2nd Mar 201812:34 pmRNSStatement re Offer for Subscription
13th Feb 20183:34 pmRNSTransaction in Own Shares
6th Feb 20185:14 pmRNSDirector/PDMR Shareholding
6th Feb 20185:13 pmRNSDirector/PDMR Shareholding
6th Feb 20185:12 pmRNSDirector/PDMR Shareholding
6th Feb 20185:06 pmRNSIssue of Equity
24th Jan 20184:41 pmRNSPublication of Suppl.Prospcts
19th Jan 20183:33 pmRNSNet Asset Value(s)
30th Nov 20174:31 pmRNSIssue of Equity
22nd Nov 20175:06 pmRNSTransaction in Own Shares
21st Nov 20173:45 pmRNSIssue of Equity
17th Nov 20175:05 pmRNSStatement re NAV and Dividend Investment Scheme
8th Nov 201710:11 amRNSResult of General Meeting
27th Oct 20173:26 pmRNSNet Asset Value(s)
25th Oct 20172:57 pmRNSDividend Declaration
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
22nd Sep 20176:25 pmRNSStatement re Offer for Subscription
15th Sep 20174:45 pmRNSIssue of Equity
15th Sep 201710:05 amRNSStatement re NAV and Dividend Investment Scheme
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
31st Aug 20175:01 pmRNSTransaction in Own Shares
25th Aug 20172:29 pmRNSHalf-year Report
10th Aug 20174:31 pmRNSDividend Declaration
25th Jul 201712:55 pmRNSForm 8.3 - Work Group PLC
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
19th Jul 201712:20 pmRNSStatement re Intended Offers for Subscription
10th Jul 201710:56 amRNSNet Asset Value(s)
15th Jun 20174:00 pmRNSDividend Declaration
12th May 20174:13 pmRNSTransaction in Own Shares
12th May 20174:07 pmRNSNet Asset Value(s)
11th May 20172:39 pmRNSTransaction in Own Shares
10th May 201712:33 pmRNSTransaction in Own Shares
28th Apr 20173:36 pmRNSDirectorate Change
27th Apr 20171:01 pmRNSNet Asset Value(s)
27th Apr 201712:57 pmRNSResult of AGM
24th Mar 20175:33 pmRNSAnnual Financial Report
26th Jan 20177:00 amRNSNet Asset Value and Proposed Final Dividend
20th Jan 201710:12 amRNSDirectorate Change
8th Nov 20164:49 pmRNSTransaction in Own Shares
7th Nov 201611:00 amRNSDirector/PDMR Shareholding
28th Oct 20168:39 amRNSNet Asset Value(s)
26th Aug 20164:36 pmRNSTransaction in Own Shares
21st Jul 20164:53 pmRNSHalf-year Report
13th Apr 20161:14 pmRNSDirectorate Change
13th Apr 20161:08 pmRNSResult of AGM
13th Apr 201612:52 pmRNSNet Asset Value(s)
11th Mar 20167:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.